Showing results (1051-1060 of 2,413) with videos related to
Sort By:
Pageof 242
Journal of Medical Economics|October 13, 2012
Ipilimumab in 2nd line treatment of patients with advanced melanoma: a cost-effectiveness analysisVictor Barzey, Michael B Atkins, Louis P Garrison, et al.Journal of Medical Economics|August 12, 2022
Evaluating the cost-utility of a direct transfer to angiosuite protocol within 6 h of symptom onset in suspected large vessel occlusion patientsManuel Requena, Valeska Seguel-Ravest, Andreu Vilaseca-Jolonch, et al.Journal of Medical Economics|August 15, 2022
Estimating the impact of biosimilar entry on prices and expenditures in rheumatoid arthritis: a case study of targeted immune modulatorsErvant J Maksabedian Hernandez, Marlon Graf, Alexandria Portelli, et al.Journal of Medical Economics|November 8, 2022
Systematic literature review of health economic models developed for multiple myeloma to support future analysesMimi Choon-Quinones, Tamás Zelei, Bertalan Németh, et al.Journal of Medical Economics|August 16, 2022
Reductions in acute medication use and healthcare resource utilization in patients with chronic migraine: a secondary analysis of a phase 3, randomized, double-blind, placebo-controlled study of galcanezumab with open-label extension (REGAIN)Joshua A Tobin, Shivang Joshi, Janet H Ford, et al.Journal of Medical Economics|May 6, 2021
Healthcare resource use and indirect costs associated with migraine in Italy: results from the My Migraine Voice surveyPaolo Martelletti, Todd J Schwedt, Pamela Vo, et al.Journal of Medical Economics|February 17, 2023
Incidence and medical costs of chronic obstructive respiratory disease in Spanish hospitals: a retrospective database analysisJosep Darbà, Meritxell AscanioJournal of Medical Economics|March 16, 2023
Treatment patterns, healthcare utilization, and costs of patients with treatment-resistant depression initiated on esketamine intranasal spray and covered by US commercial health plansKruti Joshi, Dominic Pilon, Aditi Shah, et al.Journal of Medical Economics|March 28, 2023
Cost-effectiveness of a new ACI technique for the treatment of articular cartilage defects of the knee compared to regularly used ACI technique and microfractureMartyn Snow, Vipul Mandalia, Roel Custers, et al.Journal of Medical Economics|May 21, 2020
Effects of innovation and insurance coverage on price elasticity of demand for prescription drugs: some empirical lessons in pharmacoeconomicsRoger Lee MendozaPageof 242